Table 5.
Final models for MH isolation outcomes at 10 weeks.
| Outcome | Variable | Value | OR | 95% CI | p-value |
|---|---|---|---|---|---|
| MH isolation | TxGroup | META | 1.72 | 0.84–3.55 | 0.14 |
| NO META | Ref | Ref | Ref | ||
| MDR MH isolation | TxGroup | META | 5.92 | 1.34–26.14 | 0.019 |
| NO META | Ref | Ref | Ref | ||
| Isolation of MH containing ICE | TxGroup | META | 1.88 | 0.69–5.12 | 0.21 |
| NO META | Ref | Ref | Ref |
BRD treatment (Yes or No) indicates whether an animal received antimicrobials for BRD treatment before 10 week sampling. TxGroup, treatment group; MH, Mannheimia haemolytica; BRD, bovine respiratory disease; MDR, multidrug resistant; META, tulathromycin metaphylaxis; NO META, no tulathromycin metaphylaxis; Ref, reference; OR, Odds Ratio; CI, confidence interval; ICE, integrative conjugative element.